Clinical Trials Directory

Trials / Completed

CompletedNCT05702632

TheraTogs Versus Reciprocal Electrical Stimulation on Children With Diplegic Cerebral Palsy: a Randomized Controlled Trial

Comparison of Thera-togs Orthotics With Reciprocal Electrotherapy for Postural Stability in Spastic Diplegic Cerebral Palsy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
6 Years – 8 Years
Healthy volunteers
Not accepted

Summary

Children with diplegic cerebral palsy exhibit postural restrictions as a result of both primary and secondary brain damage impairments. One of the main goals of cerebral palsy rehabilitation is to improve balance and stability. As a result, the purpose of this study is to compare the effects of TheraTogs and reciprocal electrical stimulation on postural stability in children with diplegic CP.

Conditions

Interventions

TypeNameDescription
DEVICE1- Reciprocal electrical stimulationA specialized programmable electrical stimulation device was used (Uniphy is the manufacturer of Phyaction787; Uniphy, Eindhoven, the Netherlands). The device has two channels that can alternatively stimulate two opposing groups of muscles (reciprocate).
DEVICETheraTogs orthotic treatmentA sleeveless top vest and two pairs of shorts with two thigh cuffs and limb cuffs each make up the TheraTogs strapping system which is applied to the children in the TheraTogs group. The TheraTogs suit is providing breathable, comfortable- Latex over the torso and thigh, as well as free toileting. For infection control and size fitting problems, participants are not allowed to share their TheraTogs with other patients. TheraTog's orthotic undergarment and strapping system were worn under their regular clothes, so it was neither distracting nor irritating.
PROCEDUREtraditional physical therapy programFacilitation of balance and gait training

Timeline

Start date
2022-07-15
Primary completion
2022-09-08
Completion
2022-12-30
First posted
2023-01-27
Last updated
2023-01-27

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05702632. Inclusion in this directory is not an endorsement.